Dr. rer. nat. Jörg Haupental is a senior scientist (biologist) in Prof. Anna Hirsch’s research department at HIPS. After researching novel anti-cancer drugs for several years, he started focusing on the development of anti-infective agents in 2009. In the context of the biological evaluation of novel anti-infectives (under in vivo, ex vivo and in vitro conditions) he supervises master and Ph.D. students and coordinates several technicians. Together with Prof. Dr. Anna K.H. Hirsch, he leads a CARB-X funded project aiming at the development of novel Pseudomonas aeruginosa LasB inhibitors for the treatment of acute lung infections.